Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients

Phase 1/2 Completed 132 enrolled Santen Inc.

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate if DE-101 ophthalmic suspension will safely and effectively improve signs and or symptoms of dry eye disease.

Timeline

Start: 2010-04
Primary completion: 2010-12
Completion: 2010-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Rivoglitazone	Small molecule	—	Other

Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients

Summary

Timeline

Drugs

Indications